Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The azide group is a functional group consisting of three nitrogen atoms (represented as -N3) bonded together, widely recognized in both medicinal chemistry and biochemistry. It is not a therapeutic target, such as a receptor or enzyme; instead, it is a chemical moiety that imparts specific pharmacological properties to drug molecules or acts as a potent metabolic inhibitor in its ionic form. In pharmacology, the most prominent example is Zidovudine (AZT), an antiretroviral medication where the azide group is critical for inhibiting HIV reverse transcriptase through DNA chain termination. Beyond its use in drugs, the azide group is a cornerstone of bioorthogonal 'click chemistry,' allowing for the specific labeling of biological molecules within living systems without interfering with native biochemical processes. However, in the form of sodium azide, it is highly toxic, acting similarly to cyanide by inhibiting cytochrome c oxidase and halting cellular respiration.
The azide group functions as a structural component in drugs like Zidovudine (AZT), where it acts as a DNA chain terminator by replacing the 3'-hydroxyl group, preventing further phosphodiester bond formation. As a free ion (e.g., sodium azide), it binds to the heme iron of cytochrome c oxidase, effectively blocking the electron transport chain and oxidative phosphorylation in the mitochondria.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Azide group (N3).